CATALYST PHARMACEUTICALS INC

Ticker: CPRX CUSIP: 14888U101 Class: Common Stock

Boston Partners's Holding History (CIK: 0001386060)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,231,372 Value ($000) $28,540 Avg Close $22.28 Range $19.90 - $25.14
Q3 2025
Shares 1,291,059 Value ($000) $25,577 Avg Close $20.57 Range $19.05 - $22.53
Q2 2025
Shares 1,282,722 Value ($000) $27,928 Avg Close $23.61 Range $20.40 - $26.58
Q1 2025
Shares 1,275,325 Value ($000) $30,628 Avg Close $22.52 Range $19.15 - $26.16
Q4 2024
Shares 1,291,868 Value ($000) $27,325 Avg Close $21.48 Range $19.54 - $24.27
Q3 2024
Shares 1,275,267 Value ($000) $25,565 Avg Close $18.54 Range $14.97 - $21.67
Q2 2024
Shares 1,406,380 Value ($000) $21,970 Avg Close $15.57 Range $14.47 - $17.03
Q1 2024
Shares 1,506,930 Value ($000) $23,792 Avg Close $15.07 Range $13.12 - $17.50
Q4 2023
Shares 1,541,660 Value ($000) $25,610 Avg Close $13.67 Range $11.55 - $17.40
Q3 2023
Shares 144,730 Value ($000) $1,692 Avg Close $13.38 Range $11.59 - $15.59
Q2 2023
Shares 144,730 Value ($000) $1,945 Avg Close $14.39 Range $11.09 - $18.22
Q1 2023
Shares 144,730 Value ($000) $2,400 Avg Close $16.50 Range $13.30 - $22.11
Q4 2022
Shares 144,730 Value ($000) $2,692 Avg Close $15.40 Range $12.08 - $19.78
Q3 2022
Shares 141,379 Value ($000) $1,814 Avg Close $11.85 Range $6.87 - $17.22
Q2 2022
Shares 138,558 Value ($000) $971 Avg Close $7.33 Range $6.15 - $8.65
Q1 2022
Shares 75,746 Value ($000) $628 Avg Close $7.07 Range $5.24 - $8.64